Oncotarget cover image

Oncotarget

Inhibiting Glutamine Metabolism Impacts Tumor Cells or the Microenvironment?

Aug 14, 2023
Exploring the impact of inhibiting glutamine metabolism on cancer cells and the tumor microenvironment, including targeting glutaminase, clinical studies on GLN dysregulation, and the connection with cancer-associated fibroblasts promoting cancer metastasis.
03:16

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • Inhibiting mitochondrial glutaminase can block cancer cell growth by disrupting glutamine metabolism, showing promise for novel treatment strategies.
  • Glutamine at tumor periphery attracts cancer-associated fibroblasts, aiding in cancer cell migration and metastasis in vivo.

Deep dives

Role of Glutamine Metabolism in Cancer Growth

Cancer cells exhibit an increased uptake and consumption of glucose and glutamine to sustain their rapid growth. Glutamine, besides providing precursors for the TCA cycle, is crucial for generating nitrogen-containing metabolites essential for cell cycle progression. Inhibiting mitochondrial glutaminase, a key enzyme directing glutamine into the TCA cycle, has shown promise in blocking cancer cell growth both in vivo and in vitro. Clinical studies exploring the dysregulation of glutamine metabolism to improve cancer patient survival have been conducted, but challenges arise from tumor cells' adaptability in altering their metabolism.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner